Acne Medications are medicines that are indicated for the
treatment of acne. This includes many prescription and over-the-counter
medications such as retinoids, isotretinoin, antibiotics, salicylic acid,
benzoyl peroxide, and oral contraceptives. Acne is one of the most common skin
conditions caused by changes in the structure of the skin. It affects millions
of teens around the world. It is characterized by pimples, blackheads, oily
skin and blemishes.
Explore More Insights@ https://www.alliedmarketresearch.com/request-sample/4356
There are two types of acne, non-inflammatory and
inflammatory, where the latter takes longer to heal and can have a permanent
effect on the skin. It usually affects the skin with more sweat glands than the
upper part of the chest, back and face.
The side effects associated with the use of acne drugs and
the presence of alternative treatments hinder the growth of the market. In
contrast, the development of effective drugs with low side effects and high
market potential in unused emerging economies is expected to provide profitable
growth opportunities for market growth. The increase in the prevalence of acne
is a major factor contributing to the growth of the acne drug market.
Furthermore, other factors driving the market include unhealthy urban
lifestyles and the presence of strong acne drugs in the pipeline.
Key
Advantages:
- Quantitative analysis of the current acne
medication market trends and future estimations from 2020 to 2027, which
assists in identifying prevailing acne medication market
opportunities.
- An in-depth analysis of various regions is
likely to provide a detailed understanding of the current trends to the
stakeholders to formulate region-specific plans.
- Comprehensive analysis of factors that drive
and restrain growth of the acne medication market are provided.
- Key regulatory guidelines for the acne
medication market are critically dealt according to region.
- A deep dive analysis of various regions
provides insights that would allow companies to strategically plan their
business moves.
According to a new report published by Allied Market
Research, "Acne Medicine Market: Opportunity Analysis and Industry
Forecast, 2019-2027”, The global acne drug market is valued at $ 11,865.9
million in 2019 and is projected to reach $ 13,357.57 million by 2027 at a CAGR
of 3.80% from 2020 to 2027.
Asia-Pacific is expected to record the highest CAGR in the
forecast period, due to an increase in product launches, higher demand for acne
treatments and rising healthcare costs, as well as increased awareness of newly
developed treatments that can replace traditional acne.
Key Market Players
- Almirall Sa
- Bausch Health Companies Inc.
- Glaxosmithkline Plc (Gsk)
- Johnson & Johnson
- Galderma S.A.
- Mayne Pharma Group Limited
- Mylan N.V.
- Sun Pharmaceutical Industries Limited
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd
0 Comments